Fundz

Anocca raises SEK 440 million to advance its clinical trial targeting pancreatic cancer, led by Mellby Gård with support from AMF and Ramsbury.

PRIVATEAug 18, 2025

Amount Raised

SEK440 Million

Round Type

Funding Round

SödertäljeBiotechnology

Investors

AmfRamsburyMellby Gård

Description

Anocca AB has successfully raised SEK ~440 million (USD ~46 million) to fund its gene-edited TCR-T cell therapies for pancreatic cancer. The financing will support early-stage clinical development of VIDAR-1 and Anocca’s preclinical pipeline. The company is now recruiting for Phase I of the trial at leading hospitals in Sweden, Denmark, Germany, and The Netherlands. Investors expressed strong support for Anocca's innovative approach to T-cell therapies.

Quick answer

Anocca raised SEK440 Million in a Funding Round round, dated August 18, 2025. Investors: Amf, Ramsbury and Mellby Gård. Anocca is based in Södertälje, Stockholms län, Sweden.

How much did Anocca raise?
Anocca raised SEK440 Million in a Funding Round round on August 18, 2025.
Who invested in Anocca?
Amf, Ramsbury and Mellby Gård are named as investors in this round.
What does Anocca do?
Anocca is a fully integrated biopharmaceutical company developing libraries of T cell receptor-engineered T cell (TCR-T) therapies to redefine the treatment of solid tumours.
Where is Anocca based and how big is it?
Anocca is based in Södertälje, Stockholms län, Sweden. Fundz records about 121 employees.
Who are the decision-makers at Anocca?
Fundz holds 1 contact at Anocca, including the CEO, Scientific founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Anocca that raised within 45 days of this round, from Fundz verified event records.

  • Cartography Biosciences raised $67M (Series B) on October 2, 2025.
  • Motor City Dental Partners raised an undisclosed amount (Debt Financing) on October 2, 2025.
  • Leyden Labs raised $35M (Funding Round) on October 2, 2025.
  • OncoC4 raised $50M (Series B) on October 2, 2025.
  • Kihealth raised $5M (Seed) on October 2, 2025.
  • Rockcliffe Labs raised $59M (Post-IPO Equity) on October 2, 2025.

Who to call at Anocca, and when

A new round usually means Anocca is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Anocca raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Anocca, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Anocca. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Anocca

Location

Södertälje, Stockholms län, Sweden

About

Anocca is a fully integrated biopharmaceutical company developing libraries of T cell receptor-engineered T cell (TCR-T) therapies to redefine the treatment of solid tumours. The company operates an advanced research and development infrastructure, underpinned by custom software ecosystem and in-house clinical manufacturing and process development facilities. Anocca's unique discovery platform uses programmable human cells to recreate and manipulate T cell immunity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Anocca raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsHugh S., CEO, Scientific founderSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Anocca's next move

See what Strategic adds

Anocca raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.